Compare HCA Health Inc (HCA) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Wayfair Inc — how do they compare? HCA Health Inc trades at $450.18 (market cap $96.35B), while Wayfair Inc trades at $105.74 (market cap $14.40B). The key difference: HCA Health Inc is far larger — about 6.7× Wayfair Inc's market cap, and HCA Health Inc pays a 0.7% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Wayfair Inc for 8 Days on average.
| HCA | W | |
|---|---|---|
Market Cap | $96.35B | $14.40B |
Volume | 1,079,453 | 2,102,856 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $119.05 |
52-Week Low | $361.32 | $57.40 |
Typical Hold Time | 76 Days | 8 Days |
Enterprise Value | $146.88B | $16.73B |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $451.09, up 2.71% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q4 2025 and Q1-Q2 2026 exceeding expectations, supported by robust revenue growth from $70.6B in 2024 to $75.6B in 2025. Valuation metrics remain attractive with P/E of 14.92 and P/S of 1.31, while technical indicators signal bullish momentum above key support levels.
The outlook remains positive with 63% analyst buy ratings and $461.12 consensus target, though legal investigations and high debt levels pose risks. Revenue growth and operational efficiency provide upside potential, but investors should monitor regulatory developments and debt management closely given the 80.9% debt-to-asset ratio in 2025.
Wayfair (W) trades at $105.74, up 1.22% today, with bullish technical signals from moving averages and a consensus analyst price target of $114.13. The company maintains strong revenue growth ($12.9B in 2026) but faces profitability challenges with negative net margins (-2.49%). Recent developments include the launch of the 'Wayfair Delivers' brand platform and upcoming Q3 2026 earnings on November 4, 2026.
Investment outlook remains cautiously optimistic given analyst support (54% buy ratings) and positive technical momentum, though persistent unprofitability and high debt-to-asset ratio (95% in 2025) present significant risks. The stock offers upside to price targets if margin improvements materialize, but requires monitoring of cash flow trends and competitive pressures in the retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
